GHK-Cu vs Hexarelin
A comprehensive, data-driven comparison of GHK-Cu (Copper Peptide) and Hexarelin (Examorelin). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | GHK-Cu Copper Peptide, GHK-Copper | Hexarelin Examorelin |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Anti-Aging | Growth Hormone |
| Primary Use | Skin rejuvenation and anti-aging | Growth hormone optimization and cardiac protection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $150/mo | $40 - $80/mo |
| Administration | Topical | Subcutaneous injection |
| Typical Dose | 1-2% topical cream daily, or 1-2mg injection | 100-200mcg 2x daily (pulsed use recommended) |
| Frequency | Daily | Daily |
| Mechanism | Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and has antioxidant properties | Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Hexarelin is generally more affordable ($40 - $80/mo) compared to GHK-Cu ($30 - $150/mo).
- 2GHK-Cu is administered via topical, while Hexarelin uses subcutaneous injection.
- 3GHK-Cu has moderate-quality evidence, while Hexarelin has emerging-quality evidence.
- 4They belong to different categories: GHK-Cu (Anti-Aging) vs Hexarelin (Growth Hormone).
Which Is Better For...
Hexarelin
More budget-friendly option with lower monthly costs
GHK-Cu
Fewer commonly reported side effects
GHK-Cu
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| GHK-Cu | $30 - $150/mo | Not submitted | Various research labs |
| Hexarelin | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
GHK-Cu works via Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and. Hexarelin works via Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation. They differ in FDA approval status, efficacy data, and cost.
GHK-Cu typically costs $30 - $150/mo, while Hexarelin costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
GHK-Cu is not FDA-approved (Not submitted). Hexarelin is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of GHK-Cu include Mild skin irritation (topical), Injection site reactions, Temporary copper taste. Common side effects of Hexarelin include Increased appetite, Cortisol elevation, Prolactin elevation. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
GHK-Cu is a naturally occurring copper-binding peptide found in human plasma that declines with age. It has been extensively studied for skin rejuvenation due to its ability to stimulate collagen and ...
View Full GHK-Cu GuideHexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects ind...
View Full Hexarelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between GHK-Cu and Hexarelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.